Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer

Premier sponsorship of the HERmedicine and OncoMenopause Consortium® program underscores Daré Bioscience's commitment to addressing unmet women’s health needs, including for women affected by breast cancer The program addresses non-hormonal approaches to women’s sexual health which aligns with Daré Bioscience's innovation strategy and development of proprietary Sildenafil Cream, 3.6% Daré Bioscience will also present research on Sildenafil Cream, 3.6% in postmenopausal women at The Menopause Soc